March 13th, 2011 - Volume 25 - Issue 5
pp: 547-729




The impact of HIV drug resistance testing on changes to treatment

Bansi, Loveleen; Smith, Colette; Phillips, Andrew; More

AIDS. 25(5):603-610, March 13th, 2011.

Concise Communication


Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection

Abbate, Isabella; Vlassi, Chrysoula; Rozera, Gabriella; More

AIDS. 25(5):611-617, March 13th, 2011.

Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women

Delwart, Eric; Bernardin, Flavien; Lee, Tzong-Hae; More

AIDS. 25(5):619-623, March 13th, 2011.


Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment

Harezlak, Jarek; Buchthal, Steven; Taylor, Michael; More

AIDS. 25(5):625-633, March 13th, 2011.

Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy

Chadwick, Ellen G; Yogev, Ram; Alvero, Carmelita G; More

AIDS. 25(5):643-649, March 13th, 2011.

Concise Communications


Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia

Gallien, Sébastien; Delaugerre, Constance; Charreau, Isabelle; More

AIDS. 25(5):665-669, March 13th, 2011.


CONCISE COMMUNICATIONS






1 2 3 4 5